These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2784645

  • 21. Recent data on cancer due to asbestos in the U.S.A. and Denmark.
    Nicholson WJ, Raffn E.
    Med Lav; 1995; 86(5):393-410. PubMed ID: 8684290
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR, Mason AT, Gerard JP, Henderson LE, Farrar W, Hopkins RF, Herberman RB, Rabin H.
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [Abstract] [Full Text] [Related]

  • 25. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E, Gunji Y, Herberman RB.
    J Immunol; 1988 Mar 15; 140(6):2096-102. PubMed ID: 3126240
    [Abstract] [Full Text] [Related]

  • 26. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
    Ueno Y, Miyawaki T, Seki H, Matsuda A, Taga K, Sato H, Taniguchi N.
    J Immunol; 1985 Jul 15; 135(1):180-4. PubMed ID: 3923100
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T, Belfrage H, Bhiladvala P, Hedlund G.
    J Immunol; 1987 Jun 01; 138(11):3640-5. PubMed ID: 3495566
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

  • 36. Natural killer cell-mediated antitumor reactivity of rhesus monkeys.
    Savary CA, Lotzová E, Gray KN, Jardine JH.
    Nat Immun Cell Growth Regul; 1985 Sep 01; 4(6):328-39. PubMed ID: 3878943
    [Abstract] [Full Text] [Related]

  • 37. Systemic administration of recombinant interleukin-6 in mice induces proliferation of lymphoid cells in vivo.
    Puri RK, Leland P.
    Lymphokine Cytokine Res; 1992 Jun 01; 11(3):133-9. PubMed ID: 1391232
    [Abstract] [Full Text] [Related]

  • 38. [Low susceptibility of choriocarcinoma cell lines to lymphokine activated killer (LAK) cells].
    Kameda T, Negoro T, Hagiwara M, Koyama M, Matsuzaki N, Saji F, Tanizawa O.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan 01; 41(1):1-6. PubMed ID: 2784473
    [Abstract] [Full Text] [Related]

  • 39. Effect of cortisol on the native and in vitro induced non-MHC restricted cytotoxicity of large granular lymphocytes.
    Matera L, Cardoso E, Veglia F, Cesano A, Bellone G, Vuolo A, Molinatti GM.
    J Clin Lab Immunol; 1988 Oct 01; 27(2):77-81. PubMed ID: 3266762
    [Abstract] [Full Text] [Related]

  • 40. Interleukin-2 can induce suppression of human natural killer cell cytotoxicity.
    Hellstrand K, Hermodsson S.
    Clin Exp Immunol; 1989 Sep 01; 77(3):410-6. PubMed ID: 2509116
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.